BioClec
PrivateLast Round
Seed
Mar 18, 2025
Company Overview
BioClec is a biotechnology company developing therapies for Alzheimer's disease by targeting microglia, the brain's immune cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioClec Comparables
Compare BioClec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Monument Biosciences | 86% | |
| Vigil Neuro | 77% | |
| Modulo Bio | 77% | |
BioClec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 18, 2025 |
BioClec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sofinnova Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2025
Led by Sofinnova Partners.
BioClec Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioClec's valuation, stock price, and market status.